BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sánchez-López E, Esteruelas G, Ortiz A, Espina M, Prat J, Muñoz M, Cano A, Calpena AC, Ettcheto M, Camins A, Alsafi Z, Souto EB, García ML, Pujol M. Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Nanomaterials (Basel) 2020;10:E720. [PMID: 32290252 DOI: 10.3390/nano10040720] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Roig-soriano X, Souto EB, Elmsmari F, Garcia ML, Espina M, Duran-sindreu F, Sánchez-lópez E, González Sánchez JA. Nanoparticles in Endodontics Disinfection: State of the Art. Pharmaceutics 2022;14:1519. [DOI: 10.3390/pharmaceutics14071519] [Reference Citation Analysis]
2 Fernandes AR, Vidal LB, Sánchez-López E, Dos Santos T, Granja PL, Silva AM, Garcia ML, Souto EB. Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processes. Int J Pharm 2022;623:121938. [PMID: 35728716 DOI: 10.1016/j.ijpharm.2022.121938] [Reference Citation Analysis]
3 Hanieh PN, Bonaccorso A, Zingale E, Cimarelli S, Souto EB, Rinaldi F, Marianecci C, Pignatello R, Carafa M. Almond oil O/W nanoemulsions: Potential application for ocular delivery. Journal of Drug Delivery Science and Technology 2022;72:103424. [DOI: 10.1016/j.jddst.2022.103424] [Reference Citation Analysis]
4 Mohamed HB, Attia Shafie MA, Mekkawy AI. Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model. Pharmaceutics 2022;14:893. [DOI: 10.3390/pharmaceutics14050893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Galindo R, Sánchez-López E, Gómara MJ, Espina M, Ettcheto M, Cano A, Haro I, Camins A, García ML. Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation. Pharmaceutics 2022;14:285. [PMID: 35214019 DOI: 10.3390/pharmaceutics14020285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Esteruelas G, Halbaut L, García-Torra V, Espina M, Cano A, Ettcheto M, Camins A, Souto EB, Luisa García M, Sánchez-López E. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm 2022;612:121379. [PMID: 34915146 DOI: 10.1016/j.ijpharm.2021.121379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Loftsson T. Topical drug delivery to the retina: obstacles and routes to success. Expert Opin Drug Deliv 2021;:1-13. [PMID: 34890514 DOI: 10.1080/17425247.2022.2017878] [Reference Citation Analysis]
8 Fernandes AR, Sanchez-Lopez E, Santos TD, Garcia ML, Silva AM, Souto EB. Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants. Materials (Basel) 2021;14:7541. [PMID: 34947136 DOI: 10.3390/ma14247541] [Reference Citation Analysis]
9 Kendre PN, Gite M, Jain SP, Pote A. Nanocomposite polymeric materials: state of the art in the development of biomedical drug delivery systems and devices. Polym Bull . [DOI: 10.1007/s00289-021-03985-3] [Reference Citation Analysis]
10 Folle C, Marqués AM, Díaz-Garrido N, Espina M, Sánchez-López E, Badia J, Baldoma L, Calpena AC, García ML. Thymol-loaded PLGA nanoparticles: an efficient approach for acne treatment. J Nanobiotechnology 2021;19:359. [PMID: 34749747 DOI: 10.1186/s12951-021-01092-z] [Reference Citation Analysis]
11 Silva-Abreu M, Miralles E, Kamma-Lorger CS, Espina M, García ML, Calpena AC. Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis. Pharmaceutics 2021;13:1751. [PMID: 34834165 DOI: 10.3390/pharmaceutics13111751] [Reference Citation Analysis]
12 Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H, Yang X, Liu L. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective. Int J Nanomedicine 2021;16:6497-530. [PMID: 34588777 DOI: 10.2147/IJN.S329831] [Reference Citation Analysis]
13 Dandamudi M, McLoughlin P, Behl G, Rani S, Coffey L, Chauhan A, Kent D, Fitzhenry L. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery. Pharmaceutics 2021;13:1590. [PMID: 34683883 DOI: 10.3390/pharmaceutics13101590] [Reference Citation Analysis]
14 Folle C, Díaz-Garrido N, Sánchez-López E, Marqués AM, Badia J, Baldomà L, Espina M, Calpena AC, García ML. Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment. Pharmaceutics 2021;13:1501. [PMID: 34575577 DOI: 10.3390/pharmaceutics13091501] [Reference Citation Analysis]
15 García-Torra V, Cano A, Espina M, Ettcheto M, Camins A, Barroso E, Vazquez-Carrera M, García ML, Sánchez-López E, Souto EB. State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. Toxics 2021;9:195. [PMID: 34437513 DOI: 10.3390/toxics9080195] [Reference Citation Analysis]
16 Miralles-Cardiel E, Silva-Abreu M, Calpena AC, Casals I. Development and Validation of an HPLC-MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues. Pharmaceutics 2021;13:650. [PMID: 34063615 DOI: 10.3390/pharmaceutics13050650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Machado ME, de Souza Furtado P, da Costa Bernardes Araújo C, Simon A, de Moraes MC, Rodrigues Pereira da Silva LC, do Carmo FA, Cabral LM, Sathler PC. Novel rivaroxaban-loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile. Nanotechnology 2021;32:135101. [PMID: 33276347 DOI: 10.1088/1361-6528/abd0b5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Gliszczyńska A, Sánchez-López E. Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations. Pharmaceutics 2021;13:414. [PMID: 33808908 DOI: 10.3390/pharmaceutics13030414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Grassiri B, Zambito Y, Bernkop-Schnürch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci 2021;288:102342. [PMID: 33444845 DOI: 10.1016/j.cis.2020.102342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
20 Liu YC, Lin MT, Ng AHC, Wong TT, Mehta JS. Nanotechnology for the Treatment of Allergic Conjunctival Diseases. Pharmaceuticals (Basel) 2020;13:E351. [PMID: 33138064 DOI: 10.3390/ph13110351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Baldim I, Oliveira WP, Kadian V, Rao R, Yadav N, Mahant S, Lucarini M, Durazzo A, Da Ana R, Capasso R, Souto SB, Santini A, Souto EB. Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems. Biomolecules 2020;10:E980. [PMID: 32630018 DOI: 10.3390/biom10070980] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]